Pei-Chi Yang1, Kevin R DeMarco1, Parya Aghasafari1, Mao-Tsuen Jeng1, John R D Dawson1,2, Slava Bekker3, Sergei Y Noskov4, Vladimir Yarov-Yarovoy1, Igor Vorobyov1,5, Colleen E Clancy1,5. 1. From the Department of Physiology and Membrane Biology (P.-C.Y., K.R.D., P.A., M.-T.J., J.R.D.D., V.Y.-Y., I.V., C.E.C.), University of California Davis. 2. Biophysics Graduate Group (J.R.D.D.), University of California Davis. 3. Department of Science and Engineering, American River College, Sacramento, CA (S.B.). 4. Faculty of Science, Centre for Molecular Simulations and Department of Biological Sciences, University of Calgary, Alberta, Canada (S.Y.N.). 5. Department of Pharmacology (I.V., C.E.C.), University of California Davis.
Abstract
RATIONALE: Drug-induced proarrhythmia is so tightly associated with prolongation of the QT interval that QT prolongation is an accepted surrogate marker for arrhythmia. But QT interval is too sensitive a marker and not selective, resulting in many useful drugs eliminated in drug discovery. OBJECTIVE: To predict the impact of a drug from the drug chemistry on the cardiac rhythm. METHODS AND RESULTS: In a new linkage, we connected atomistic scale information to protein, cell, and tissue scales by predicting drug-binding affinities and rates from simulation of ion channel and drug structure interactions and then used these values to model drug effects on the hERG channel. Model components were integrated into predictive models at the cell and tissue scales to expose fundamental arrhythmia vulnerability mechanisms and complex interactions underlying emergent behaviors. Human clinical data were used for model framework validation and showed excellent agreement, demonstrating feasibility of a new approach for cardiotoxicity prediction. CONCLUSIONS: We present a multiscale model framework to predict electrotoxicity in the heart from the atom to the rhythm. Novel mechanistic insights emerged at all scales of the system, from the specific nature of proarrhythmic drug interaction with the hERG channel, to the fundamental cellular and tissue-level arrhythmia mechanisms. Applications of machine learning indicate necessary and sufficient parameters that predict arrhythmia vulnerability. We expect that the model framework may be expanded to make an impact in drug discovery, drug safety screening for a variety of compounds and targets, and in a variety of regulatory processes.
RATIONALE: Drug-induced proarrhythmia is so tightly associated with prolongation of the QT interval that QT prolongation is an accepted surrogate marker for arrhythmia. But QT interval is too sensitive a marker and not selective, resulting in many useful drugs eliminated in drug discovery. OBJECTIVE: To predict the impact of a drug from the drug chemistry on the cardiac rhythm. METHODS AND RESULTS: In a new linkage, we connected atomistic scale information to protein, cell, and tissue scales by predicting drug-binding affinities and rates from simulation of ion channel and drug structure interactions and then used these values to model drug effects on the hERG channel. Model components were integrated into predictive models at the cell and tissue scales to expose fundamental arrhythmia vulnerability mechanisms and complex interactions underlying emergent behaviors. Human clinical data were used for model framework validation and showed excellent agreement, demonstrating feasibility of a new approach for cardiotoxicity prediction. CONCLUSIONS: We present a multiscale model framework to predict electrotoxicity in the heart from the atom to the rhythm. Novel mechanistic insights emerged at all scales of the system, from the specific nature of proarrhythmic drug interaction with the hERG channel, to the fundamental cellular and tissue-level arrhythmia mechanisms. Applications of machine learning indicate necessary and sufficient parameters that predict arrhythmia vulnerability. We expect that the model framework may be expanded to make an impact in drug discovery, drug safety screening for a variety of compounds and targets, and in a variety of regulatory processes.
Authors: Zhihua Li; Sara Dutta; Jiansong Sheng; Phu N Tran; Wendy Wu; Kelly Chang; Thembi Mdluli; David G Strauss; Thomas Colatsky Journal: Circ Arrhythm Electrophysiol Date: 2017-02
Authors: Haibo Ni; Alex Fogli Iseppe; Wayne R Giles; Sanjiv M Narayan; Henggui Zhang; Andrew G Edwards; Stefano Morotti; Eleonora Grandi Journal: Br J Pharmacol Date: 2020-08-09 Impact factor: 8.739
Authors: Albert J Rogers; Anojan Selvalingam; Mahmood I Alhusseini; David E Krummen; Cesare Corrado; Firas Abuzaid; Tina Baykaner; Christian Meyer; Paul Clopton; Wayne Giles; Peter Bailis; Steven Niederer; Paul J Wang; Wouter-Jan Rappel; Matei Zaharia; Sanjiv M Narayan Journal: Circ Res Date: 2020-11-10 Impact factor: 17.367
Authors: Dominic G Whittaker; Rebecca A Capel; Maurice Hendrix; Xin Hui S Chan; Neil Herring; Nicholas J White; Gary R Mirams; Rebecca-Ann B Burton Journal: R Soc Open Sci Date: 2021-04-13 Impact factor: 2.963